Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Rang in Aktien #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Aktienkurs
$44.60
Marktkapitalisierung
$108.62B
Veränderung (1 Tag)
-1.63%
Veränderung (1 Jahr)
-21.62%
Land
FR
Handel Sanofi (SNY)

Kategorie

Umsatz von Sanofi (SNY)
Umsatz im Dec 2025 TTM: $54.81B
Laut den aktuellen Finanzberichten von Sanofi beträgt der derzeitige Umsatz des Unternehmens (TTM) $54.81B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $46.08B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $46.01B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Sanofi von 2000 bis 2026
Umsatz am Ende jedes Jahres
Jahr Umsatz ändert
2026 (TTM) $54.81B 0.00%
2025 $54.81B 18.94%
2024 $46.08B 0.16%
2023 $46.01B 5.74%
2022 $43.51B -2.33%
2021 $44.55B -2.12%
2020 $45.51B 7.79%
2019 $42.22B 2.98%
2018 $41.00B -5.67%
2017 $43.46B 19.05%
2016 $36.51B -3.56%
2015 $37.85B -2.23%
2014 $38.72B -10.02%
2013 $43.03B -9.28%
2012 $47.43B 4.51%
2011 $45.38B -0.27%
2010 $45.51B 3.21%
2009 $44.09B 9.79%
2008 $40.16B -5.93%
2007 $42.69B 10.03%
2006 $38.80B 15.26%
2005 $33.66B 57.92%
2004 $21.32B 110.71%
2003 $10.12B 29.32%
2002 $7.82B 35.65%
2001 $5.77B 3.32%
2000 $5.58B 0.00%
Umsatz vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Umsatz Umsatzunterschied Land
$65.18B 18.92%
US
$58.74B 7.17%
GB
$94.19B 71.85%
US
$61.16B 11.58%
US
$56.15B 2.44%
CH